HPV examination for consistency recognition and chances stratification
The Aptima HPV analyze and Aptima HPV 16 18/45 genotype test target HPV kinds that position the greatest hazard to people. 2,3 While more HPV assays desired DNA, the Aptima HPV assays focus mRNA, which studies also show reflects the presence and exercise of bad HPV disease. 2,3 The Aptima HPV assay finds E6/E7 mRNA, that’s indicative of those HPV problems almost certainly going to bring cervical condition. 2 The Aptima HPV 16 18/45 genotype substance identifies HPV type 16, 18 and 45, which might be associated with over to 80% almost all invasive cervical varieties of cancer around the world. 3,15-16
Testing lady with Aptima HPV assays allow service providers improve look after each person.
The ThinPrep system facilitate maximize clinical workflow
The ThinPrep Pap challenge is truly one of a few solutions through the ThinPrep system. The ThinPrep processors, imagers and review scopes help improve workflow in research laboratory and assist with cytotechnologistsa€™ capability decide problems. These tools assist execute the ThinPrep process and make the most of clinical efficiency and reliability in infection detection.
In addition to the ThinPrep Pap taste, Hologic continues to be purchased supplying research laboratory with ground breaking and effective cytology treatments for non-gynecological examination desires.
From Pap and HPV testing to your full range of symptomatic products and cross-divisional innovative developments such as the Genius 3D Mammography test for chest overall health, Hologic delivers for ladies. Our guarantee to offer you creative remedies to get to know the needs of females throughout the world lingers throughout all those things you do, most notably in cervical problem checking. Collaborating, we could obtain the goal of conquering cervical illness.
a multifaceted approach for womena€™s natural overall health
For more information regarding the Aptima + ThinPrep Cervical medical portfolio, browse HealthDxS.
* Aptima HPV assay, Aptima HPV 16 18/45 Genotype test, Cervista HPV hour test, Cervista HPV 16/18 test, Roche cobas HPV test and Hybrid get 2 HPV DNA taste.
Mention: 1. ThinPrep 2000 Processor [instructions for use]. MAN-02624-001, Rev. 005. Marlborough, MA: Hologic, Inc.; 2017. 2. Aptima HPV test [package insert]. AW-12820-001, Rev. 001. North Park, CA: Hologic, Inc.; 2015. 3. Aptima HPV Genotype 16 18/45 assay [package insert]. AW-12821-001, Rev. 001. North Park, CA: Hologic, Inc.; 2015. 4. Blatt AJ, et al. Review of cervical malignant tumors screening listings among 256,648 ladies in multiple scientific methods. Disease Cytopathol. 2015;123(5):282-288 [Study included ThinPrep, SurePath, cross Capture 2 assay]. 5. Saslow D, et al. United states Cancer world, American Our society for Colposcopy and Cervical Pathology, and American Our society for medical Pathology screening instructions for cures and very early recognition of cervical cancers. CA Disease J Clin. 2012; 62(3):147-172. 6. The American School of Obstetricians and Gynecologists. Practise publication 168: testing for cervical cancer tumors. Obstet Gynecol. 2016;128(4):3111-30. doi:10.1097/ AOG.0000000000001708. 7. Centers for problems Management and avoidance. Cervical Cancer Tumors are Avoidable. s://www.cdc.gov/vitalsigns/cervical-cancer/index.html. Up-to-date December 5, 2014. Utilized December 29, 2017. 8. Domestic Cancers Institute. SEER Stat Concept Covers: Cervix Uteri Cancer Tumors. ://seer.cancer.gov/statfacts/html/cervix.html. Printed 2016. Accessed December 4, 2017. 9. National Institutes of Fitness. NIH Reality Sheets: Cervical Cancers. ://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=76. Up To Date March 29, 2013. Accessed November 29, 2017. 10. Hologic, Inc. Records on File. 11. Hologic, Inc. Point of view Printed Records: Direct-to-Vial Scientific Studies. s://healthdxs/en/view-published-data/. Utilized November 29, dating app for Kink 2017. 12. Eversole GM, et al. Procedures of players for the school of United states Pathologists interlaboratory review course in cervicovaginal cytology, 2006. Posture Pathol Research Med. 2010;134(3):331-5. doi:10.1043/1543-2165-134.3.331. 13. Adegoke O, et al. Cervical disease Trends in the us: A 35-Year Population-Based test. J Female Medical. 2012;21(10):1031-1037. 14. PrepStain Method [product insert]. 779-07085-00, Rev. F. Burlington, NC: TriPath Imaging, Inc., 2011. 15. Li N, ainsi, al. Peoples papillomavirus type circulation in 30,848 invasive cervical varieties of cancer globally: difference by geographic place, histological means and seasons of publishing. Int J Cancer Tumors. 128:927-935. doi:10.1002/ijc.25396. 16. De Sanjose S, ainsi, al. 2010. Real person papillomavirus genotype attribution in invasive cervical malignant tumors: a retrospective cross-sectional globally analysis. Lancet. doi:10.1016/S1470-2045(10)70230-8.
Data offered about this bill is intended for readers outside the US. Inquire „USA“ tab for products and assertions for sale in the United States.